Product Pipeline
Ambit is currently in product development of the following:
» Quizartinib (FLT3/KIT) » AC480 (panHER) » AC430 (JAK2) » CEP32496 (BRAF) » CSF1R ProgramUpcoming Conferences & Events
- 02.27.12 - New York, NY –Citi 2012 Global Health Care Conference
- 02.27.12 – Vancouver, Canada – 10th Annual BioPartnering North America Conference
- 03.06.2012 – Boston, MA – 32nd Annual Cowen and Company Health Care Conference
Press ReleasesRSS
- 02.22.12Ambit Biosciences to Present at the Citi Global Health Care Conference
- 02.09.12Ambit Biosciences to Present at Two Upcoming Investor Conferences
- 02.08.12Ambit Biosciences Appoints Athena Countouriotis as Chief Medical Officer
- 01.10.12Ambit Biosciences To Present At 30TH Annual J.P. Morgan Healthcare Conference
- 12.16.11Ambit and Astellas Announce Results From Multiple Quizartinib Presentations At The 53rd Annual Meeting Of The American Hematology Society